Latest Laxmi Dental stock price
Laxmi Dental P/E Ratio
LAXMIDENTL • P/E ratio trend, valuation band, and sector comparison — all formatted to support journal-based trading review.
Current P/E Ratio
42.57
High Valuation
Very High - High growth expectations or significantly overvalued
Current Valuation Metrics
P/E Ratio
42.57
Current Price
₹258.40
EPS (TTM)
₹6.07
Exchange
NSE
Valuation Signal
Signal
Overvalued
Sector Context
Sector Average
55.0
Sector Median
36.22
Sector Rank
#11 of 86
Sector Percentile
12.8%
Earnings Breakdown (TTM)
TTM EPS
₹6.03
Sept 2025
₹1.59
Mar 2025
₹0.79
Key P/E Ratio Insights for Laxmi Dental
- Stock appears overvalued with PE of 42.57, suggesting caution for new investments
- Trading at discount to sector average PE of 55.0
View the LAXMIDENTL equity price for detailed stock performance.
Related Pages for Laxmi Dental
Additional stock information and data for LAXMIDENTL
Sector P/E Ratio Comparison
Comparing Laxmi Dental with other companies in Healthcare sector
Sector Average
55.0
Sector Median
36.22
Lowest P/E
9.01
Highest P/E
515.32
Companies
86
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Fermenta Biotech | FERMENTA | 9.01 | ₹1,010 | Low |
| Natco Pharma | NATCOPHARM | 10.8 | ₹17,006 | Low |
| Mohini Health & Hygiene | MHHL | 11.84 | ₹69 | Low |
| Lincoln Pharmaceuticals | LINCOLN | 12.02 | ₹974 | Low |
| QMS Medical Allied Servi… | QMSMEDI | 12.82 | ₹177 | Low |
| Take Solutions | TAKE | 13.15 | ₹638 | Low |
| Venus Remedies | VENUSREM | 14.27 | ₹995 | Low |
| Royal Sense | ROYAL | 14.5 | ₹96 | Low |
| Bliss GVS Pharma | BLISSGVS | 16.62 | ₹1,973 | Moderate |
| RPG Life Sciences | RPGLIFE | 17.94 | ₹3,861 | Moderate |